The small molecule penalty is a threat to health equity
By Kevin B. Kimble A seemingly minor provision in last year’s Inflation Reduction Act could make it harder for marginalized patients to access the medicines their doctors have prescribed. It could also prevent the future development of cutting-edge, convenient treatments for many diseases that disproportionately impact communities of color. The Inflation Reduction Act allows the…
